Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10573-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10573-1-AP, RRID:AB_2156986
- Product name
- OTUB1 antibody
- Antibody type
- Polyclonal
- Description
- OTUB1 antibody (Cat. #10573-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references OTUB1 stabilizes PRRSV matrix protein through a non-canonical deubiquitination mechanism to promote viral replication.
OTUB1 enhances fatty acid oxidation in APAP-induced liver injury by mediating ACSL5 deubiquitination.
Primary Cilia Formation Mediated by Hsa_Circ_0005185/OTUB1/RAB8A Complex Inhibits Prostate Cancer Progression by Suppressing Hedgehog Signaling Pathway.
OTUB1 mediates PARP1 deubiquitination to alleviate NAFLD by regulating HMGB1.
CircSCD1 inhibits ferroptosis in breast Cancer through stabilizing SCD1 protein via deubiquitinase OTUB1.
Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting.
Liu B, Liang W, Li X, Jiang S, Shi Z, Liu N, Zhu R, Dong X, Zhou H, Zhou B, Cui J
Journal of virology 2026 Apr 21;100(4):e0186825
Journal of virology 2026 Apr 21;100(4):e0186825
OTUB1 enhances fatty acid oxidation in APAP-induced liver injury by mediating ACSL5 deubiquitination.
Guo S, Zhao Y, Wang Y, Lin M, Luan Q, Hu Z, Zhao X, Tian X, Wang Z, Yao J
Biochemical pharmacology 2025 Jul;237:116957
Biochemical pharmacology 2025 Jul;237:116957
Primary Cilia Formation Mediated by Hsa_Circ_0005185/OTUB1/RAB8A Complex Inhibits Prostate Cancer Progression by Suppressing Hedgehog Signaling Pathway.
Fan A, Zhang Y, Li Y, Meng W, Wu F, Pan W, Ma Z, Chen W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(8):e2411675
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(8):e2411675
OTUB1 mediates PARP1 deubiquitination to alleviate NAFLD by regulating HMGB1.
Ai S, Pan J, Liu Q, Tang F, Wen T, Yuan Y, He Q, Huang L
Experimental cell research 2025 Feb 1;445(1):114425
Experimental cell research 2025 Feb 1;445(1):114425
CircSCD1 inhibits ferroptosis in breast Cancer through stabilizing SCD1 protein via deubiquitinase OTUB1.
Wu Z, Zhang F, Yang K, He W
Scientific reports 2025 Apr 10;15(1):12351
Scientific reports 2025 Apr 10;15(1):12351
Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
Li H, Zhu X, Sun Z, Wang Q, Song S, Xu Y, He G, Mao X
ACS pharmacology & translational science 2024 Jan 12;7(1):176-185
ACS pharmacology & translational science 2024 Jan 12;7(1):176-185
Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting.
Olie CS, Riaz M, Konietzny R, Charles PD, Pinto-Fernandez A, Kiełbasa SM, Aartsma-Rus A, Goeman JJ, Kessler BM, Raz V
iScience 2019 Feb 22;12:318-332
iScience 2019 Feb 22;12:318-332
No comments: Submit comment
No validations: Submit validation data